Back to Results
First PageMeta Content
Pharmacology / Medicare Part D / Medical prescription / Generic drug / Medicare Prescription Drug / Improvement / and Modernization Act / Medicare / Health care in the United States / Copayment / Health insurance / Pharmaceuticals policy / Pharmaceutical sciences / Health


No[removed]IN THE Supreme Court of the United States FEDERAL TRADE COMMISSION, Petitioner,
Add to Reading List

Document Date: 2013-02-28 15:04:06

Open Document

File Size: 149,43 KB

Share Result on Facebook

Company

THIS CASE1 AHIP / WATSON PHARMACEUTICALS INC. / THIS CASE / SERVICE AND SOURCE OF FUNDS / /

Continent

America / /

Country

United States / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

THE Supreme Court / /

IndustryTerm

generic pharmaceuticals / distribution chain / retail price / retail pharmacy counter / payer prescription drug insurance benefits / health insurance / individual insurance market / healthcare / health insurance industry / /

Organization

Congress / TATES SENATE ON BARRIERS TO GENERIC ENTRY / FTC’s Bureau of Competition / UNITED STATES SENATE ON BARRIERS TO GENERIC ENTRY / Supreme Court / RADE COMMISSION / U.S. Census Bureau / FDA / United States FEDERAL TRADE COMMISSION / United States Government Accountability Office / MEDICARE / /

/

Position

Counsel / /

Product

testosterone / Androgel / pricing / /

ProvinceOrState

New York / /

Technology

http / pdf / /

URL

http /

SocialTag